The contribution of hormonal profile changes to determining cardiac prognosis in patients with stable coronary artery disease undergoing coronary revascularization

Read full text Summarise with VIRAT
Authors: A. O. Lobe, Д. Н. Иванченко, Н. П. Дорофеева, Л. А. Хаишева
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

One of the factors influencing cardiac prognosis is changes in the balance of hormonal and metabolic parameters in the blood, particularly leptin, resistin, and testosterone, which are involved in chronic subclinical inflammation. The potential for using these markers in clinical practice formed the basis for the development of a prognostic model for determining cardiac prognosis after percutaneous coronary interventions with coronary artery stenting in patients with stable coronary artery disease, which was the aim of this study. It was shown that increased leptin and resistin levels, as well as decreased serum testosterone levels in patients with stable coronary artery disease, are associated with an increased risk of adverse cardiovascular outcomes within a year of coronary revascularization. In addition, an assessment was made of the influence of leptin, resistin, and testosterone levels on the outcome within 12 months after myocardial revascularization by constructing a prognostic model that allows assessing the likelihood of developing adverse cardiac events.

Fields of Study & Subjects

Inflammatory Biomarkers in Disease Prognosis Coronary Interventions and Diagnostics Hormonal and reproductive studies

Publication details

Journal / source
South Russian Journal of Therapeutic Practice
Volume
7
Issue
1
Pages
47–54
Publication date
27 March 2026
Language
EN